Related content

The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice

By Kemper E.   Cleypool Cindy   Boogerd Willem   Beijnen Jos   Tellingen Olaf  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 173-178

Springer Publishing Company

Access to resources Recommend Favorite

Internal tandem duplication and tyrosine kinase domain mutations in FLT3 alter the response to daunorubicin in Ba/F3 cells

By    

Biomedical Reports, Vol. 4, Iss. 1, 2016-01 ,pp. : 83-86

Science Publishers

Access to resources Recommend Favorite

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients

By Henningsson A.   Sparreboom A.   Sandstrom M.   Freijs A.   Larsson R.   Bergh J.   Nygren P.   Karlsson M.O.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1105-1114

Elsevier

Access to resources Recommend Favorite

LY294002 prevents lipopolysaccharideinduced hepatitis in a murine model by suppressing IκB phosphorylation

By          

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 811-816

Spandidos Publications

Access to resources Recommend Favorite

LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 575-579

Spandidos Publications

Access to resources Recommend Favorite